Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.
Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.
Exp Neurol. 2017 Jul;293:62-73. doi: 10.1016/j.expneurol.2017.03.019. Epub 2017 Mar 27.
Vasoactive intestinal peptide (VIP) is one of the neuropeptides showing the strongest up-regulation in the nociceptive pathway after peripheral nerve injury and has been proposed to support neuropathic pain. Nevertheless, the story may be more complicated considering the known suppressive effects of the peptide on the immune reactivity of microglial cells, which have been heavily implicated in the onset and maintenance of pain after nerve injury. We here used mice deficient in VIP and the model of spared nerve injury, characterized by persistent tactile hypersensitivity. While tactile hypersensitivity developed similarly to wild type mice for the ipsilateral hindpaw, only transgenic mice showed a mirror-image tactile hypersensitivity in the contralateral hindpaw. This exacerbated neuropathic pain phenotype appeared to be mediated through a local mechanism acting at the level of the lumbar spinal cord as a distant nerve lesion in the front limb did not lead to hindpaw hypersensitivity in VIP-deficient mice. Innocuous tactile hindpaw stimulation was found to increase a neuronal activation marker in the bilateral superficial laminae of the lumbar dorsal horn of VIP-deficient, but not wild type mice, after SNI. A deeper study into the immune responsiveness to the nerve lesion also proved that VIP-deficient mice had a stronger early pro-inflammatory cytokine response and a more pronounced microglial reactivity compared to wild type controls. The latter was also observed at four weeks after spared nerve injury, a time at which bilateral tactile hypersensitivity persisted in VIP-deficient mice. These data suggest an action of VIP in neuropathic states that is more complicated than previously assumed. Future research is now needed for a deeper understanding of the relative contribution of receptors and fiber populations involved in the VIP-neuropathic pain link.
血管活性肠肽(VIP)是在外周神经损伤后在痛觉通路中表现出最强上调的神经肽之一,被认为支持神经性疼痛。然而,考虑到该肽对小胶质细胞免疫反应的已知抑制作用,情况可能会更加复杂,小胶质细胞在神经损伤后疼痛的发生和维持中起着重要作用。我们在这里使用 VIP 缺乏的小鼠和 spared nerve injury 模型,其特征是持续的触觉过敏。虽然对同侧后爪而言,触觉过敏在野生型小鼠和 VIP 缺乏型小鼠中的发展相似,但只有转基因小鼠在对侧后爪中表现出镜像触觉过敏。这种加剧的神经性疼痛表型似乎是通过一种局部机制介导的,该机制作用于腰椎脊髓水平,因为前肢的远处神经损伤不会导致 VIP 缺乏型小鼠的后爪过敏。在 SNI 后,我们发现无害的触觉后爪刺激会增加 VIP 缺乏型小鼠双侧浅层腰椎背角的神经元激活标记物,但不会增加野生型小鼠的神经元激活标记物。对免疫反应性的更深入研究还证明,与野生型对照相比,VIP 缺乏型小鼠在神经损伤后早期具有更强的促炎细胞因子反应和更明显的小胶质细胞反应。这种情况也在 spared nerve injury 后四周观察到,此时 VIP 缺乏型小鼠双侧触觉过敏持续存在。这些数据表明 VIP 在神经性疼痛状态下的作用比以前假设的更为复杂。现在需要进行进一步的研究,以更深入地了解参与 VIP-神经性疼痛联系的受体和纤维群体的相对贡献。